The serum, produced by Argentine biotechnology company Inmunova, is obtained by injecting a SARS-CoV-2 protein, which causes the animal to generate a large amount of neutralizing antibodies. Plasma is then extracted from the horse, purified and processed. (The Guardian)

#COVID19

#Covidargentina

#Pandemic

#SARS

#Inmunova

#Plasmatherapy

#immunesystem

#biotechnology

#clinicalstudies

#ArgentinaIndia